天美影院

Explore our comprehensive portfolio that addresses the complete care continuum for many of the world鈥檚 most threatening diseases. 

Shape 25 Spotlight
Industry trends

Insights
Conferences & events

Discover the stories of pioneers pushing the boundaries of what鈥檚 possible in healthcare to help improve people鈥檚 lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers posts strong Q2 results; adjusted basic earnings per share range widened for outlook due to tariffs
Press release

Siemens Healthineers posts strong Q2 results; adjusted basic earnings per share range widened for outlook due to tariffs

Siemens Healthineers AG today announces its results for the second quarter of fiscal year 2025 ended March 31, 2025.
Published on May 7, 2025

Q2 Fiscal Year 2025 

  • Very good equipment book-to-bill ratio of 1.14
  • Strong comparable revenue growth of 6.8% 
  • Imaging comparable revenue growth of 8.7%; very good adjusted EBIT margin of 22.4% 
  • Diagnostics comparable revenue growth of 1.0%; adjusted EBIT margin of 6.3% 
  • Varian comparable revenue growth of 12.5%; adjusted EBIT margin of 13.2% mainly due to extraordinarily high equipment revenue share 
  • Advanced Therapies comparable revenue growth of 3.7%; very good adjusted EBIT margin of 18.5% 
  • Overall adjusted EBIT margin of 16.6%, clearly above prior-year quarter 
  • Free cash flow of almost 鈧200 million, clearly above prior-year quarter 
  • Adjusted basic earnings per share of 鈧0.56, above prior-year quarter

Updated Outlook for Fiscal Year 2025 

We confirm our expectation of comparable revenue growth of between 5% to 6% compared with fiscal year 2024. Due to the geopolitical developments 鈥 in particular trade barriers and increased tariffs on a wide range of countries 鈥 we now assume an expanded range of between 鈧2.20 and 鈧2.50 (previously 鈧2.35 to 鈧2.50) for adjusted basic earnings per share.

 Bernd Montag, CEO of Siemens Healthineers AG: 

鈥漌e continued our strong start to the fiscal year in the second quarter. While the fundamental growth drivers remain intact, we expect that the significantly increased volatility of the geopolitical environment will weigh on our business this year. That leads us to widen our guidance range for adjusted basic earnings per share for fiscal 2025, while keeping our revenue growth outlook unchanged.鈥

(pdf, 265.42 KB)

Siemens Healthineers 2025

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around 鈧22.4 billion. Further information is available at www.siemens-healthineers.com.